Belsomra, a medication used to treat insomnia, can cause several side effects. Common adverse reactions reported include drowsiness, dizziness, and abnormal dreams [1]. Other frequently observed side effects include fatigue, headache, and an increased susceptibility to upper respiratory tract infections [1].
What are the less common Belsomra side effects?
Some individuals may experience less frequent side effects such as diarrhea, nausea, and dry mouth [1]. Patients have also reported symptoms like anxiety, irritability, and temporary memory impairment [1]. In rare cases, more serious side effects can occur.
Can Belsomra cause complex sleep behaviors?
Yes, Belsomra, like other medications in its class, carries a risk of causing complex sleep behaviors. These can include sleepwalking, sleep-driving, making phone calls, or preparing and eating food while not fully awake, with no memory of the event afterward [1]. If a patient experiences any of these, they should discontinue the medication immediately [1].
What are the risks associated with stopping Belsomra?
Abruptly stopping Belsomra may lead to withdrawal symptoms, including rebound insomnia [1]. It is generally recommended that patients discuss with their healthcare provider before discontinuing the medication to manage potential withdrawal effects [1].
How does Belsomra work in the brain?
Belsomra's mechanism of action involves selectively blocking the binding of orexin to its receptors. Orexin is a neurotransmitter that plays a role in promoting wakefulness. By inhibiting orexin signaling, Belsomra helps to reduce wakefulness and facilitate sleep [1].
When did Belsomra receive FDA approval?
Belsomra (suvorexant) was approved by the U.S. Food and Drug Administration (FDA) in August 2014 [2].
What are the available dosages for Belsomra?
Belsomra is available in several strengths, typically including 5 mg, 10 mg, 15 mg, and 20 mg tablets [1].
Sources:
1. DrugPatentWatch.com
2. FDA